MORPHOSYS revenue breakdown overview

MORPHOSYS revenue for the last year amounted to 221.45 M CHF, the most of which — 221.43 M CHF — came from its highest performing source at the moment, Innovative Cancer Medicines, the year earlier bringing 275.40 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought MORPHOSYS 196.52 M CHF.